| Issue |
J Extra Corpor Technol
Volume 20, Number 4, December 1988
|
|
|---|---|---|
| Page(s) | 134 - 137 | |
| DOI | https://doi.org/10.1051/ject/1988204134 | |
| Published online | 25 August 2023 | |
Editorial review/Future direction
Supported Angioplasty: A New Contribution for Extra-Corporeal Circulation Technology
1
PSICOR Inc, San Diego, California, USA
2
Lubbock Cardiology Associates Inc Lubbock, Texas, USA
* PSICOR Inc 16818 Via del Campo Court San Diego, CA 92127 USA
To date there have been no fewer than seven palliative treatments for atherosclerotic coronary artery disease. The expanding role of interventional cardiology in the treatment of patients with severe coronary artery disease will result in a mandatory and significant allocation of perfusion services dedicated to the catheterization laboratory.
Historical, and now more recent data, indicate that femoro-femoral bypass can be utilized as a resuscitative tool and as an adjunct to interventional cardiology techniques. The role of the perfusion team in the catheterization lab will evolve and expand along with the growing application of interventional cardiology techniques.
Key words: Femora-femoral bypass / supported angioplasty / PTCA / coronary reperfusion / interventional cardiology
© 1988 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.